{
    "id": 25517,
    "fullName": "PDK1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PDK1 over exp indicates an over expression of the Pdk1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5163,
        "geneSymbol": "PDK1",
        "terms": [
            "PDK1"
        ]
    },
    "variant": "over exp",
    "createDate": "10/17/2016",
    "updateDate": "07/11/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19418,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, head and neck squamous cell carcinoma cells harboring NOTCH1 C478F and overexpressing PDK1 demonstrated a decrease in apoptotic activity compared to the cells not overexpressing PDK1 when treated with GSK2126458 (PMID: 30770351).",
            "molecularProfile": {
                "id": 34089,
                "profileName": "NOTCH1 C478F PDK1 over exp"
            },
            "therapy": {
                "id": 763,
                "therapyName": "GSK2126458",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 16991,
                    "pubMedId": 30770351,
                    "title": "PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30770351"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 19419,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, head and neck squamous cell carcinoma cells harboring NOTCH1 E1679* and overexpressing PDK1 demonstrated a decrease in apoptotic activity compared to the cells not overexpressing PDK1 when treated with GSK2126458 (PMID: 30770351).",
            "molecularProfile": {
                "id": 34090,
                "profileName": "NOTCH1 E1679* PDK1 over exp"
            },
            "therapy": {
                "id": 763,
                "therapyName": "GSK2126458",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 16991,
                    "pubMedId": 30770351,
                    "title": "PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30770351"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 19420,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, head and neck squamous cell carcinoma cells harboring NOTCH1 Q1957* and overexpressing PDK1 demonstrated a decrease in apoptotic activity compared to the cells not overexpressing PDK1 when treated with GSK2126458 (PMID: 30770351).",
            "molecularProfile": {
                "id": 34091,
                "profileName": "NOTCH1 Q1957* PDK1 over exp"
            },
            "therapy": {
                "id": 763,
                "therapyName": "GSK2126458",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 16991,
                    "pubMedId": 30770351,
                    "title": "PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30770351"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26509,
            "profileName": "PDK1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34089,
            "profileName": "NOTCH1 C478F PDK1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34090,
            "profileName": "NOTCH1 E1679* PDK1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34091,
            "profileName": "NOTCH1 Q1957* PDK1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}